Ozempic in India
Ozempic price and availability in India — an honest guide.
What semaglutide actually costs in India today, what's officially available, and how clinical GLP-1 programs compare with self-sourcing from grey-market channels.
What Ozempic is
What it costs in India
How to access it safely
Is semaglutide available in India?
Semaglutide reaches Indian patients through three channels today. The most accessible is Rybelsus — the oral tablet formulation, formally approved and stocked at major pharmacies. The second is Wegovy, the higher-dose semaglutide approved specifically for chronic weight management, which began a phased Indian launch in 2025 in select metros.
Ozempic itself — the injectable semaglutide branded for type 2 diabetes — is not yet broadly marketed through Indian retail pharmacies. Where it appears, it is usually through hospital channels or named-patient imports, with pricing that reflects import duties and a limited supply chain.
Tirzepatide (Mounjaro), a dual GIP/GLP-1 receptor agonist, is also now commercially available in India at a similar premium price point and is often discussed alongside semaglutide for eligible adults.
Estimated monthly cost in India
Indicative ranges only — actual prices vary by city, dose strength, import channel and timing. Always confirm with a licensed pharmacy.
| Medication | Form | Typical monthly cost (INR) | Availability |
|---|---|---|---|
| Rybelsus (oral semaglutide) | Tablet, daily | ₹3,000–₹6,000 (3 mg start) | Widely available |
| Wegovy (semaglutide 2.4 mg) | Weekly injection | ₹17,000–₹26,000 | Select metros (2025+) |
| Ozempic (semaglutide) | Weekly injection | ₹18,000–₹26,000 (imported) | Limited / named-patient |
| Mounjaro (tirzepatide) | Weekly injection | ₹17,000–₹28,000 | Commercially available |
Clinical program vs self-sourcing
The headline price of a single pen looks attractive next to a monthly program fee. But a stalled, unsafe or counterfeit course of GLP-1 is meaningfully more expensive than a supervised one — in money, in time, and in side-effect risk. Programs bundle eligibility review, supervised titration, side-effect management and tracking around a verified supply.
What to watch out for
- Online listings far below typical pen pricing — almost always counterfeit.
- Cold-chain failures — semaglutide pens must stay refrigerated.
- Self-escalation past the recommended dose schedule.
- No clinician overseeing nausea, reflux or other side effects.
Frequently asked
- Is Ozempic available in India in 2026?
- Ozempic (semaglutide injection by Novo Nordisk) is not yet broadly marketed in India through retail pharmacies. Limited supply reaches the country through hospital channels and named-patient imports. The oral semaglutide tablet Rybelsus is the formally approved branded option in India today, and Wegovy (a higher-dose semaglutide for chronic weight management) launched in select Indian metros in 2025.
- How much does Ozempic cost in India?
- Where it is privately imported, a single 1.5 ml Ozempic pen (which typically lasts about a month at low-to-mid doses) is commonly quoted between ₹18,000 and ₹26,000 depending on dose strength, source and city. Prices fluctuate with import availability and the rupee-dollar rate — treat any single number as an estimate, not a list price.
- How does that compare with Rybelsus and Wegovy in India?
- Rybelsus (oral semaglutide) is the most accessible branded option and usually costs ₹3,000–₹6,000 for a 30-tablet pack at the lower 3 mg dose, scaling up at 7 mg and 14 mg. Wegovy pricing in India was announced in 2025 in the range of ₹17,000–₹26,000 per month depending on dose. Tirzepatide (Mounjaro) is also commercially available in India at a similar premium price point.
- What does a clinical GLP-1 program cost vs. self-sourcing?
- Self-sourcing pays only for the vial or pen — but you also carry the risk of counterfeit product, cold-chain failure, wrong dose titration and unmanaged side effects. A clinician-guided program bundles eligibility review, supervised titration, side-effect management and ongoing tracking around a verified medication supply. The all-in cost is higher than a single pen, but materially lower than the cost of a stalled or unsafe attempt.
- Can I buy Ozempic online in India?
- We do not recommend it. Online listings for Ozempic in India are frequently grey-market, unregulated, or outright counterfeit. GLP-1 medications are prescription-only and require clinician oversight for dose escalation and safety monitoring. MedAstra only works with medications routed through licensed clinical channels.
- Who is GLP-1 therapy actually for?
- GLP-1 medications are intended for adults meeting specific BMI and metabolic criteria, after a clinician-led eligibility review. They are not lifestyle drugs, not for cosmetic weight loss in healthy-weight adults, and not suitable during pregnancy or with certain medical conditions.
Want a deeper read on how semaglutide actually works? Read the semaglutide guide, the Wegovy guide, or the tirzepatide guide.
This page is educational only. It is not medical advice and should not be used to self-prescribe. Suitability for any GLP-1 medication — including semaglutide, Wegovy or tirzepatide — is determined by a qualified clinician based on your full medical history.
Ready to see if GLP-1 support is right for you?
Start with a structured eligibility check. No commitment, no pressure to begin medication.